Found: 50
Select item for more details and to access through your institution.
Activated CD8<sup>+</sup>CD38<sup>+</sup> Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.861666
- By:
- Publication type:
- Article
Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 65, doi. 10.1007/s40261-020-00981-9
- By:
- Publication type:
- Article
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.
- Published in:
- Allergy, 2024, v. 79, n. 5, p. 1123, doi. 10.1111/all.15982
- By:
- Publication type:
- Article
Eosinophils—from cradle to grave: An EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion.
- Published in:
- Allergy, 2023, v. 78, n. 12, p. 3077, doi. 10.1111/all.15884
- By:
- Publication type:
- Article
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper.
- Published in:
- Allergy, 2023, v. 78, n. 11, p. 2835, doi. 10.1111/all.15817
- By:
- Publication type:
- Article
Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma.
- Published in:
- Allergy, 2023, v. 78, n. 2, p. 559, doi. 10.1111/all.15513
- By:
- Publication type:
- Article
Physical exercise, immune response, and susceptibility to infections—current knowledge and growing research areas.
- Published in:
- Allergy, 2022, v. 77, n. 9, p. 2653, doi. 10.1111/all.15328
- By:
- Publication type:
- Article
Cysteinyl–leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2549, doi. 10.1111/all.15319
- By:
- Publication type:
- Article
Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2337, doi. 10.1111/all.15258
- By:
- Publication type:
- Article
The ICQ asthma algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management.
- Published in:
- Allergy, 2022, v. 77, n. 4, p. 1325, doi. 10.1111/all.15131
- By:
- Publication type:
- Article
Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives.
- Published in:
- Allergy, 2021, v. 76, n. 6, p. 1640, doi. 10.1111/all.14840
- By:
- Publication type:
- Article
COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper.
- Published in:
- Allergy, 2021, v. 76, n. 3, p. 648, doi. 10.1111/all.14453
- By:
- Publication type:
- Article
Immune modulation via T regulatory cell enhancement: Disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO).
- Published in:
- Allergy, 2021, v. 76, n. 1, p. 90, doi. 10.1111/all.14478
- By:
- Publication type:
- Article
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I.
- Published in:
- Allergy, 2021, v. 76, n. 1, p. 114, doi. 10.1111/all.14295
- By:
- Publication type:
- Article
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.
- Published in:
- Allergy, 2020, v. 75, n. 12, p. 3039, doi. 10.1111/all.14582
- By:
- Publication type:
- Article
A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2.
- Published in:
- Allergy, 2020, v. 75, n. 10, p. 2503, doi. 10.1111/all.14449
- By:
- Publication type:
- Article
Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Response to mepolizumab in patients with severe CRSwNP using response criteria.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Effect of montelukast on excessive airway narrowing response to methacholine in adult asthmatic patients not on controller therapy.
- Published in:
- Allergy & Asthma Proceedings, 2009, v. 30, n. 1, p. 64, doi. 10.2500/aap.2009.30.3196
- By:
- Publication type:
- Article
Can a single dose response predict the effect of montelukast on exercise-induced bronchoconstriction?
- Published in:
- Pediatric Pulmonology, 2016, v. 51, n. 5, p. 470, doi. 10.1002/ppul.23324
- By:
- Publication type:
- Article
Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 1, p. 65, doi. 10.1111/cea.14149
- By:
- Publication type:
- Article
Toward effective prescription of inhaled corticosteroids in chronic airway disease.
- Published in:
- International Journal of COPD, 2018, v. 13, p. 3419, doi. 10.2147/COPD.S174216
- By:
- Publication type:
- Article
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00543-5
- By:
- Publication type:
- Article
Personalized Approach to Severe Asthma.
- Published in:
- BioMed Research International, 2018, p. 1, doi. 10.1155/2018/2465172
- By:
- Publication type:
- Article
Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fcimb.2021.646688
- By:
- Publication type:
- Article
A EUFOREA comment on a lost comorbidity of asthma.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2023, v. 19, n. 1, p. 1, doi. 10.1186/s13223-023-00816-0
- By:
- Publication type:
- Article
Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study.
- Published in:
- 2020
- By:
- Publication type:
- clinical trial
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up.
- Published in:
- International Forum of Allergy & Rhinology, 2024, v. 14, n. 1, p. 18, doi. 10.1002/alr.23219
- By:
- Publication type:
- Article
Clinical aspects of using exhaled NO in asthma diagnosis and management.
- Published in:
- Clinical Respiratory Journal, 2012, v. 6, n. 4, p. 193, doi. 10.1111/crj.12001
- By:
- Publication type:
- Article
The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma.
- Published in:
- Allergy, 2020, v. 75, n. 9, p. 2170, doi. 10.1111/all.14177
- By:
- Publication type:
- Article
COVID‐19, chronic inflammatory respiratory diseases and eosinophils—Observations from reported clinical case series.
- Published in:
- Allergy, 2020, v. 75, n. 7, p. 1819, doi. 10.1111/all.14353
- By:
- Publication type:
- Article
Blood eosinophils: In quest of a Holy Grail for personalized asthma treatment with biologicals.
- Published in:
- Allergy, 2020, v. 75, n. 6, p. 1294, doi. 10.1111/all.14253
- By:
- Publication type:
- Article
Point‐of‐care biomarkers in asthma management: Time to move forward.
- Published in:
- Allergy, 2020, v. 75, n. 4, p. 995, doi. 10.1111/all.14045
- By:
- Publication type:
- Article
EUFOREA consensus on biologics for CRSwNP with or without asthma.
- Published in:
- Allergy, 2019, v. 74, n. 12, p. 2312, doi. 10.1111/all.13875
- By:
- Publication type:
- Article
Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care.
- Published in:
- Allergy, 2019, v. 74, n. 12, p. 2293, doi. 10.1111/all.13851
- By:
- Publication type:
- Article
Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases.
- Published in:
- Allergy, 2019, v. 74, n. 11, p. 2064, doi. 10.1111/all.13856
- By:
- Publication type:
- Article
The potential role of CD16<sup>high</sup>CD62L<sup>dim</sup> neutrophils in the allergic asthma.
- Published in:
- Allergy, 2019, v. 74, n. 11, p. 2265, doi. 10.1111/all.13861
- By:
- Publication type:
- Article
Toward clinically applicable biomarkers for asthma: An EAACI position paper.
- Published in:
- Allergy, 2019, v. 74, n. 10, p. 1835, doi. 10.1111/all.13806
- By:
- Publication type:
- Article
Much ado about Biologicals: Highlights of the Master Class on Biologicals, Prague, 2018.
- Published in:
- Allergy, 2019, v. 74, n. 4, p. 837, doi. 10.1111/all.13688
- By:
- Publication type:
- Article
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper.
- Published in:
- Allergy, 2019, v. 74, n. 3, p. 432, doi. 10.1111/all.13642
- By:
- Publication type:
- Article
Which Biomarkers Are Effective for Identifying Th2-Driven Inflammation in Asthma?
- Published in:
- Current Allergy & Asthma Reports, 2013, v. 13, n. 5, p. 477, doi. 10.1007/s11882-013-0376-6
- By:
- Publication type:
- Article
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.
- Published in:
- Clinical Science, 2023, v. 137, n. 9, p. 727, doi. 10.1042/CS20190281
- By:
- Publication type:
- Article
Single- and multiple-dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects.
- Published in:
- Fundamental & Clinical Pharmacology, 2014, v. 28, n. 6, p. 690, doi. 10.1111/fcp.12079
- By:
- Publication type:
- Article
Mepolizumab reduces disease symptoms for patients with chronic rhinosinusitis with nasal polyps: Data from the SYNAPSE study.
- Published in:
- Rhinology Supplement, 2021, v. 61, p. 286
- By:
- Publication type:
- Article
European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
- Published in:
- Rhinology Supplement, 2020, v. 58, p. 1
- By:
- Publication type:
- Article
European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
- Published in:
- Rhinology, 2020, v. 58, p. I, doi. 10.4193/rhin20.600
- By:
- Publication type:
- Article
Effect of an NK<sub>1</sub>/NK<sub>2</sub> Receptor Antagonist on Airway Responses and Inflammation to Allergen in Asthma.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2007, v. 175, n. 5, p. 450, doi. 10.1164/rccm.200608-1186OC
- By:
- Publication type:
- Article
Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics.
- Published in:
- 2022
- By:
- Publication type:
- journal article